HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Bezitramide

HCID 61791
NotesReactions
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
15301-48-1
Standard SMILES
CCC(=O)n1c(=O)n(C2CCN(CCC(C#N)(c3ccccc3)c3ccccc3)CC2)c2ccccc21
InChIKey
FLKWNFFCSSJANB-UHFFFAOYSA-N
Molecular formula
C31H32N4O2
Average molar mass
492.6 g/mol
Monoisotopic mass
492.25252628

Overview

Bezitramide is a nitrile.

Names & identifiers

Preferred name
Bezitramide
IUPAC
4-[4-(2-oxo-3-propanoylbenzimidazol-1-yl)piperidin-1-yl]-2,2-diphenylbutanenitrile
English name
bezitramide
Molecular formula
C31H32N4O2
Molecular weight
492.61

Names & synonyms

BEZITRAMIDEBurgodinBezitramida15301-48-1BezitramidumR-4845R 4845Bezitramide [INN:BAN:DCF]3KXW0Y310IIDS-NB-007N02AC051-(1-(3-Cyano-3,3-diphenylpropyl)-4-piperidyl)-3-propionyl-2-benzimidazolinone
Show more names
FLKWNFFCSSJANB-UHFFFAOYSA-N1-[1-(3-Cyano-3,3-diphenylpropyl)-4-piperidinyl]-1,3-dihydro-3-(1-oxopropyl)-2H-benzimidazol-2-one1-Piperidinebutanenitrile, 4-[2,3-dihydro-2-oxo-3-(1-oxopropyl)-1H-benzimidazol-1-yl]-α,α-diphenyl-
1-(3-Cyano-3,3-diphenylpropyl)-4-(2-oxo-3-propionyl-1-benzimidazolinyl)piperidineDTXSID90165197Bezitramide (INN:BAN:DCF)RefChem:119583DTXCID2087688239-335-44-(4-(2-oxo-3-propanoyl-2,3-dihydro-1H-1,3-benzodiazol-1-yl)piperidin-1-yl)-2,2-diphenylbutanenitrileBenzitramide

Database identifiers

CAS
15301-48-1
PubChem CID
61791
DTXSID
DTXSID90165197
ChEMBL
CHEMBL2104149

Properties

Computed structural properties

XLogP
5
Topological polar surface area
67.7 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
4
Rotatable bonds
7
Heavy atoms
37
Formal charge
0
Complexity
827

Experimental & physicochemical properties

Drugs · 4 items

DEA NFLIS-Drug Category -> Narcotic Analgesics

DEA Schedule II Controlled Substance -> Opiates

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds

LogP4.8
SolubilityPoor water solubility
Melting Point145-149 °C

Physicochemical properties

Melting point
145 · 145-149°; mp 124.5-126°
Boiling point
586.35 °C · 586.35°C (rough estimate)
Density
1.147 · 1.1470 (rough estimate)
refractive index
1.6 · 1.6000 (estimate)
solubility
10 mg/ml · DMSO: Soluble: = 10 mg/ml
pka
8.21 · 8.21±0.10(Predicted)
color
White, crystalline powder

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Hazard information

Regulatory InformationDEA schedule II controlled substance

Safety data

Toxicity
LD50 orally in mice, rats: 2101, 141 mg/kg (Janssen)

Chemistry & industry

Pharmacology

ATC Code · 2 items

N - Nervous system

QN - Nervous system

Pharmacodynamics · 1 item

Bezitramide acts in the body to relieve pain with a potency 20 times that of methadone. Its duration of action is relatively long, lasting up to 12 hours post oral administration, after the achievement of steady state. Its onset of action is slow, with a peak in analgesic effect noted between 2.5-3.5 hours after dosing. It is noted to illicit a strong antitussive effect, which could be of benefit to patients with bronchial carcinoma.

Biological Half-Life11-24h.
Metabolism/Metabolites · 1 item

Bezitramide is a prodrug which undergoes rapid hydrolysis of a proprionyl-group to form the major metabolite, R-4618. R-4618 has analgesic properties similar to the parent compound. Metabolism occurs in the gastrointestinal tract under both acidic and alkaline conditions.

MeSH Pharmacological ClassificationCompounds capable of relieving pain without the loss of CONSCIOUSNESS.
Absorption, Distribution and Excretion · 2 items

Bezitramide has poor water solubility, thus administration is restricted to the oral route.

Less than 0.3% of the dose was excreted unchanged in the urine. High concentrations in feces suggested incomplete absorption of biliary excretion. Experiments in rats demonstrated extensive (up to 70%) biliary excretion, and less than 3% urinary excretion.

Applications

UsesBezitramide is a narcotic analgesic agonist with modified pipiridine N-substituents whose binding affinity to the ORL1 and N-methyl-D-aspartate (NMDA) receptors is of research interest.

Upstream & downstream products

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
ChEBI
CHEBI:135794
UNII
3KXW0Y310I
EC Number
239-335-4
Nikkaji
J8.541C
FDA UNII
3 KXW0Y310I · 3KXW0Y310I
ATC code
2 AC05 · N02AC05
Toxicity
50 orally · LD50 orally in mice, rats: 2101, 141 mg/kg (Janssen)

Upstream raw materials

Sodium carbonatePropionic anhydride4-Bromo-6,7-dimethoxyindanone4-(2-Keto-1-benzimidazolinyl)piperidinePotassium iodide

Additional notes

DefinitionChEBI: Bezitramide is a nitrile.